Literature DB >> 15809061

Cationic lipids enhance siRNA-mediated interferon response in mice.

Zheng Ma1, Jiang Li, Fengtian He, Annette Wilson, Bruce Pitt, Song Li.   

Abstract

RNA interference mediated by small interfering RNAs (siRNAs) shows promise as a powerful research tool for gene function studies. However, controversy exists over the potential of siRNA-induced interferon response in vitro and in vivo. In this study, we showed that although intravenous administration of siRNA alone is essentially inert, injection of siRNA complexed with cationic liposomes resulted in a potent induction of both type I and type II interferon responses. Furthermore, i.v. administration of cationic lipid/siRNA complexes led to activation of STAT1. This study suggests caution in data interpretation and the potential toxicity with in vivo use of siRNA, particularly when delivered via a cationic lipid vector. This study also suggests the potential of siRNA as an immunostimulatory agent for immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809061     DOI: 10.1016/j.bbrc.2005.03.041

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  60 in total

Review 1.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

Review 2.  Silence of the transcripts: RNA interference in medicine.

Authors:  Sailen Barik
Journal:  J Mol Med (Berl)       Date:  2005-07-19       Impact factor: 4.599

3.  Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA).

Authors:  Michael J Wagner; Rahul Mitra; Mark J McArthur; Wallace Baze; Kirstin Barnhart; Sherry Y Wu; Cristian Rodriguez-Aguayo; Xinna Zhang; Robert L Coleman; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2017-03-06       Impact factor: 6.261

Review 4.  Delivery technologies for cancer immunotherapy.

Authors:  Rachel S Riley; Carl H June; Robert Langer; Michael J Mitchell
Journal:  Nat Rev Drug Discov       Date:  2019-03       Impact factor: 84.694

5.  Global gene expression profiling in cultured cells is strongly influenced by treatment with siRNA-cationic liposome complexes.

Authors:  Tatsuaki Tagami; Kiyomi Hirose; Jose Mario Barichello; Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  Pharm Res       Date:  2008-06-26       Impact factor: 4.200

Review 6.  Lipidic systems for in vivo siRNA delivery.

Authors:  Sherry Y Wu; Nigel A J McMillan
Journal:  AAPS J       Date:  2009-09-09       Impact factor: 4.009

Review 7.  Strategies for targeted nonviral delivery of siRNAs in vivo.

Authors:  Sang-Soo Kim; Himanshu Garg; Anjali Joshi; N Manjunath
Journal:  Trends Mol Med       Date:  2009-10-19       Impact factor: 11.951

8.  Relationships between liposome properties, cell membrane binding, intracellular processing, and intracellular bioavailability.

Authors:  Yinghuan Li; Jie Wang; Yue Gao; Jiabi Zhu; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2011-09-10       Impact factor: 4.009

Review 9.  New short interfering RNA-based therapies for glomerulonephritis.

Authors:  Hideki Shimizu; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

10.  Combined genome-wide expression profiling and targeted RNA interference in primary mouse macrophages reveals perturbation of transcriptional networks associated with interferon signalling.

Authors:  Paul Lacaze; Sobia Raza; Garwin Sing; David Page; Thorsten Forster; Petter Storm; Marie Craigon; Tarif Awad; Peter Ghazal; Tom C Freeman
Journal:  BMC Genomics       Date:  2009-08-10       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.